Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

César Serrano

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Current Opinion in Oncology|April 19, 2021
New treatments in advanced gastrointestinal stromal tumorCésar Serrano
Current Oncology Reports|January 21, 2022
New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal TumorsCésar Serrano, Sebastian Bauer
Hematology/Oncology Clinics of North America|October 8, 2013
LeiomyosarcomaCésar Serrano, Suzanne George
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2020
Gastrointestinal Stromal Tumor: Challenges and Opportunities for a New DecadeCésar Serrano, Suzanne George
Therapeutic Advances in Medical Oncology|May 3, 2014
Recent advances in the treatment of gastrointestinal stromal tumorsCésar Serrano, Suzanne George
Signal Transduction and Targeted Therapy|February 4, 2026
It's a kind of MAGIC: uncovering the origins of chromosomal instabilityDavid Gómez-Peregrina, César Serrano
Frontiers in Oncology|February 6, 2023
Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE databaseRoberto Carmagnani Pestana, César Serrano
Expert Review of Anticancer Therapy|August 18, 2021
Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacyMiguel Henriques-Abreu, César Serrano
Oncotarget|November 8, 2019
Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumorCésar Serrano, Jonathan A Fletcher
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Integration of anti-epidermal growth factor receptor therapies with cytotoxic chemotherapyCésar Serrano, Ben Markman, Josep Tabernero
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Current Opinion in Oncology|April 19, 2021
New treatments in advanced gastrointestinal stromal tumorCésar Serrano
Current Oncology Reports|January 21, 2022
New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal TumorsCésar Serrano, Sebastian Bauer
Hematology/Oncology Clinics of North America|October 8, 2013
LeiomyosarcomaCésar Serrano, Suzanne George
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2020
Gastrointestinal Stromal Tumor: Challenges and Opportunities for a New DecadeCésar Serrano, Suzanne George
Therapeutic Advances in Medical Oncology|May 3, 2014
Recent advances in the treatment of gastrointestinal stromal tumorsCésar Serrano, Suzanne George
Signal Transduction and Targeted Therapy|February 4, 2026
It's a kind of MAGIC: uncovering the origins of chromosomal instabilityDavid Gómez-Peregrina, César Serrano
Frontiers in Oncology|February 6, 2023
Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE databaseRoberto Carmagnani Pestana, César Serrano
Expert Review of Anticancer Therapy|August 18, 2021
Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacyMiguel Henriques-Abreu, César Serrano
Oncotarget|November 8, 2019
Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumorCésar Serrano, Jonathan A Fletcher
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Integration of anti-epidermal growth factor receptor therapies with cytotoxic chemotherapyCésar Serrano, Ben Markman, Josep Tabernero
Pageof 9